Liquid biopsy, Lung cancer screening, Smoking cessation, Locally advanced NSCLC, Early-stage NSCLC, Adjuvant therapy, Mesothelioma, Squamous cell carcinoma, Thymic tumors, The new staging system, Advanced NSCLC, Supportive therapy, Biomarkers and targeted therapy, Immunotherapy
Corey J. Langer, MD, FACP, Director of Thoracic Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
This event offers
12.5 CME credits
Accredited by NACCME and Imedex.